Development of the Perinatal Depression Inventory (PDI)-14 using item response theory: a comparison of the BDI-II, EPDS, PDI, and PHQ-9

The objective of this study is to develop a simple, brief, self-report perinatal depression inventory that accurately measures severity in a number of populations. Our team developed 159 Likert-scale perinatal depression items using simple sentences with a fifth-grade reading level. Based on iterative cognitive interviewing (CI), an expert panel improved and winnowed the item pool based on pre-determined criteria. The resulting 67 items were administered to a sample of 628 pregnant and 251 postpartum women with different levels of depression at private and public sector obstetrics clinics, together with the Beck Depression Inventory (BDI-II), Edinburg Postpartum Depression Scale (EPDS), and the Patient Health Questionnaire (PHQ-9), as well as Module A of the Structured Clinical Interview for DSM-IV Diagnoses (SCID). Responses were evaluated using Item Response Theory (IRT). The Perinatal Depression Inventory (PDI)-14 items are highly informative regarding depression severity and function similarly and informatively across pregnant/postpartum, white/non-white, and private-clinic/public-clinic populations. PDI-14 scores correlate well with the PHQ-9, EPDS, and BDI-II, but the PDI-14 provides a more precise measure of severity using far fewer words. The PDI-14 is a brief depression assessment that excels at accurately measuring depression severity across a wide range of severity and perinatal populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00737-015-0553-9) contains supplementary material, which is available to authorized users

Lipopeptide secondary metabolites from the phytopathogenic bacterium Pseudomonas syringae.

Over the past twenty years or so, significant advances have been made in the study of the secondary metabolism of the widespread phytopathogenic Gram-negative bacterium Pseudomonas syringae. Interdisciplinary approach, which required the expertise of plant pathologists, chemists, biochemists and molecular biologists, led to the discovery of a new family of bioactive peptide secondary metabolites. The determination of their structures was pivotal for the investigations on their biosynthetic pathways, their relevance in the development of plant disease, and for the understanding of the molecular bases of their biological activities in plant, microbial and animal cells. In particular, the antibiotic activities of some of these compounds appear very interesting in the perspective of their utilization both in medicine and in agriculture. The goal of this chapter is to summarize the present knowledge in various areas of research on P. syringae peptide metabolites